Compare SPXC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPXC | TECH |
|---|---|---|
| Founded | 1912 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.2B |
| IPO Year | 1994 | 1995 |
| Metric | SPXC | TECH |
|---|---|---|
| Price | $210.90 | $52.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $250.63 | $73.09 |
| AVG Volume (30 Days) | 331.3K | ★ 2.1M |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.59% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | ★ 5.03 | 0.49 |
| Revenue | ★ $2,265,100,000.00 | $1,219,635,000.00 |
| Revenue This Year | $14.21 | $2.49 |
| Revenue Next Year | $7.92 | $6.40 |
| P/E Ratio | ★ $40.64 | $109.96 |
| Revenue Growth | ★ 14.17 | 5.23 |
| 52 Week Low | $115.00 | $46.02 |
| 52 Week High | $246.68 | $72.16 |
| Indicator | SPXC | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 33.03 |
| Support Level | $201.97 | $48.52 |
| Resistance Level | $227.43 | $54.08 |
| Average True Range (ATR) | 8.43 | 2.31 |
| MACD | -3.62 | -0.33 |
| Stochastic Oscillator | 22.92 | 8.56 |
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.